Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 17/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4061076 | 0.88 | SLC6A2 (0.62) | SLC6A2SLC6A3SLC6A4KCNH2HTR1A | |
| SCHEMBL4060478 | 0.86 | SLC6A2 (0.70) | SLC6A2SLC6A3SLC6A4KCNH2 | |
| SCHEMBL4943281 | 0.79 | SLC6A2 (0.76) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL3617038 | 0.79 | SLC6A2 (1.00) | SLC6A2SLC6A3SLC6A4KCNH2 | |
| SCHEMBL4055833 | 0.79 | SLC6A2 (1.00) | SLC6A2SLC6A3SLC6A4KCNH2 | |
| SCHEMBL3603690 | 0.79 | SLC6A2 (0.81) | SLC6A2SLC6A3SLC6A4KCNH2 | |
| SCHEMBL4061277 | 0.75 | SLC6A2 (0.77) | SLC6A2SLC6A3SLC6A4KCNH2 | |
| SCHEMBL4063830 | 0.75 | SLC6A2 (0.50) | SLC6A2SLC6A3SLC6A4KCNH2 | |
| SCHEMBL13673700 | 0.74 | SLC6A2 (0.75) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL4060482 | 0.74 | SLC6A2 (0.58) | SLC6A2SLC6A3SLC6A4KCNH2DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080194654-A1 | HYDROXY-SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194654-A1 | HYDROXY-SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | SLC6A4, SLC6A2, TPH1 | SLC6A2 2/4885SLC6A3 7/4885SLC6A4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.